Literature DB >> 9125168

Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE).

T C Hsieh1, M E Aguero-Rosenfeld, J M Wu, C Ng, N A Papanikolaou, S A Varde, I Schwartz, J G Pizzolo, M Melamed, H W Horowitz, R B Nadelman, G P Wormser.   

Abstract

Human granulocytic ehrlichiosis (HGE) is an emerging and occasionally fatal human infectious disease whose pathogenesis is largely unknown. Goodman et al. (1) recently described the successful cultivation of the HGE infectious agent in human promyelocytic HL-60 leukemic cells. It was reported in the same study that infectivity invariably led to host cell death, although the mechanism by which HGE infection triggers cellular self-destruction is as yet undetermined. In this communication, we show that in vitro passage of HGE pathogen-infected blood elicits a significantly dysfunctional G1-to-S transition. Moreover, we provide evidence that the cytopathic properties of the HGE pathogen are attributed to its ability to induce apoptosis in host HL-60 cells. Determination of specific protein expression changes by Western blot analysis showed that HGE infection resulted in reduced expression of PCNA and pRB, both of which play a role in cell cycling. Moreover, the steady state level of bcl-2, which protects eukaryotic cells against apoptosis, is suppressed by exposure to the HGE agent. These results suggest that this pathogen HGE induces apoptosis in HL-60 cells by a mechanism involving the shut-off of multiple cell cycle and apoptosis regulatory events.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125168     DOI: 10.1006/bbrc.1997.6276

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Anaplasma phagocytophilum infection induces apoptosis in HL-60 cells.

Authors:  Pratap Karki; Jacob W Ijdo
Journal:  World J Microbiol Biotechnol       Date:  2011-11-01       Impact factor: 3.312

2.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway.

Authors:  Kyoung-Seong Choi; Joon Tae Park; J Stephen Dumler
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Jason A Carlyon; Ji-Lian Cai; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis.

Authors:  K Yoshiie; H Y Kim; J Mott; Y Rikihisa
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats.

Authors:  P Caturegli; K M Asanovich; J J Walls; J S Bakken; J E Madigan; V L Popov; J S Dumler
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis.

Authors:  M E Martin; K Caspersen; J S Dumler
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

8.  Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin.

Authors:  Kyoung-Seong Choi; Justin Garyu; Jinho Park; J Stephen Dumler
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo.

Authors:  Helena Scaife; Zerai Woldehiwet; C Anthony Hart; Steven W Edwards
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.